| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/IAI.00157-16 |
| P8608 | Fatcat ID | release_t2xrzkq72jdslfjxq2dznht7cq |
| P932 | PMC publication ID | 4962623 |
| P698 | PubMed publication ID | 27245410 |
| P50 | author | Michael F. Good | Q6830168 |
| Ian Cockburn | Q43190684 | ||
| Jennifer M Reiman | Q56778536 | ||
| Denise L Doolan | Q61822031 | ||
| Danielle I Stanisic | Q86061713 | ||
| P2093 | author name string | Stephen L Hoffman | |
| Sumana Chakravarty | |||
| Penny Groves | |||
| Yeping Cai | |||
| Virginia McPhun | |||
| Amber I Raja | |||
| P2860 | cites work | Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria | Q21032534 |
| Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production | Q24676570 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| CD4 T-cell subsets in malaria: TH1/TH2 revisited | Q26849470 | ||
| Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice | Q27317107 | ||
| The tissue stages and sporogony of Plasmodium knowlesi | Q28181690 | ||
| Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis | Q28262934 | ||
| Highly sensitive quantitative real-time PCR for the detection of Plasmodium liver-stage parasite burden following low-dose sporozoite challenge | Q28533999 | ||
| Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites | Q28541281 | ||
| A proteomic view of the Plasmodium falciparum life cycle | Q29618807 | ||
| Cross-species malaria immunity induced by chemically attenuated parasites | Q33570804 | ||
| Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin | Q33735095 | ||
| Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria | Q33769200 | ||
| Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes | Q33883479 | ||
| Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 | ||
| Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally | Q34109384 | ||
| Cytokines in the pathogenesis of and protection against malaria | Q34174462 | ||
| Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity | Q34214786 | ||
| Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection | Q34239730 | ||
| Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial | Q34359432 | ||
| Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine | Q34362872 | ||
| A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine | Q34487139 | ||
| Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites | Q35051549 | ||
| Protection of Malian children from clinical malaria is associated with recognition of multiple antigens | Q35094826 | ||
| Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization | Q35211003 | ||
| Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria | Q35546069 | ||
| Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites | Q35606514 | ||
| Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction | Q35709003 | ||
| Plasmodium sporozoites trickle out of the injection site | Q35783390 | ||
| The origins, function, and regulation of T follicular helper cells | Q36118326 | ||
| In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines | Q36375434 | ||
| Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection | Q36411599 | ||
| A combined transcriptome and proteome survey of malaria parasite liver stages | Q36423509 | ||
| Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice. | Q36483596 | ||
| Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites | Q36523062 | ||
| Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge | Q36920497 | ||
| Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii | Q36987901 | ||
| Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness | Q37099503 | ||
| IL-10: the master regulator of immunity to infection | Q37143028 | ||
| A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali | Q37267850 | ||
| CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites | Q37483705 | ||
| Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum | Q39362892 | ||
| Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes | Q39571544 | ||
| Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to plasmodium falciparum malaria | Q40585807 | ||
| Lymphocyte life-span and memory | Q40695854 | ||
| Frequencies of CD4+ T cells reactive with Plasmodium chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection | Q41268000 | ||
| Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage | Q41337172 | ||
| Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites | Q41386252 | ||
| Cytotoxic activities of CD8⁺ T cells collaborate with macrophages to protect against blood-stage murine malaria | Q41438284 | ||
| Quantitation of malaria sporozoites transmitted in vitro during salivation by wild Afrotropical Anopheles | Q44143722 | ||
| Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi | Q44145270 | ||
| Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. | Q44146651 | ||
| Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy | Q45126363 | ||
| A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene | Q46098688 | ||
| First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children | Q46182948 | ||
| Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial | Q46623264 | ||
| Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya | Q46884256 | ||
| A genetic investigation of virulence in a rodent malaria parasite | Q47848050 | ||
| Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease | Q47848282 | ||
| Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami | Q47886950 | ||
| A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea | Q47901914 | ||
| Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain | Q47925938 | ||
| Plasmodium yoelii can ablate vaccine-induced long-term protection in mice | Q48013326 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium yoelii | Q12065970 |
| P304 | page(s) | 2274-2288 | |
| P577 | publication date | 2016-07-21 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection | |
| P478 | volume | 84 |
| Q94606070 | A genetically hmgb2 attenuated blood stage P. berghei induces crossed-long live protection |
| Q58560720 | A step forward for an attenuated blood-stage malaria vaccine |
| Q47106697 | Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium |
| Q39259814 | Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine |
| Q57462998 | Controlled infection immunization using delayed death drug treatment elicits protective immune responses to blood-stage malaria parasites |
| Q40083759 | Immunological memory to blood-stage malaria infection is controlled by the histamine releasing factor (HRF) of the parasite. |
| Q55403419 | Induction of immunity following vaccination with a chemically attenuated malaria vaccine correlates with persistent antigenic stimulation. |
| Q96607419 | Malaria vaccines since 2000: progress, priorities, products |
| Q92183845 | Mannosylated liposomes formulated with whole parasite P. falciparum blood-stage antigens are highly immunogenic in mice |
| Q60956648 | Metformin Promotes the Protection of Mice Infected With Independently of γδ T Cell Expansion |
| Q57180542 | Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study |
Search more.